P 
0.07
+6.28%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About PURE Biosciences
From its filings with the US Securities and Exchange Commission
PURE Biosciences is based in El Cajon, California and is incorporated in Delaware. Its shares trade on OTC under the ticker PURE. The SEC classifies its business as miscellaneous chemical products. In the fiscal year to 31 July 2026, it reported revenue of $2.3m and a net loss of $2.5m. At that date it held total assets of $1.2m and shareholders' equity of −$6.4m.
Company facts
- Sector
- Consumer Staples
- Industry
- Household Products
- Listed since
- 8 Aug 1996
- Employees
- 10
- Website
- purebio.com ↗
- Head office
- 771 JAMACHA ROAD #512, EL CAJON, CA, 92019
- Incorporated in
- DE
- Classification
- Miscellaneous Chemical Products
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Ivan ChenIndependent Chairman of the Board$52,500
- Mr. Robert BartlettPresident, Chief Executive Officer, Director, since 2023$215,000
- Mr. Mark ElliottVice President Finance and Principal Financial and Accounting Officer$195,000
- Mr. Tom MyersExecutive Vice President - Technology and Development, Director, since 2018$215,000
- Mr. Tom LeeDirector, since 2014$42,000
- Mr. Bernard BlotnerIndependent Director$46,000
- Mr. David RendallIndependent Director$46,000
- Mr. Darin ZehrIndependent Director$8,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- PURE Biosciences Inc has several key strengths that contribute to its success in the market. Firstly, the company has developed a portfolio of innovative bioscience technologies and products. These technologies offer unique and effective solutions for various applications and industries.
- Secondly, PURE Biosciences Inc benefits from a strong research and development team. This team is comprised of highly skilled and experienced professionals who are dedicated to pushing the boundaries of bioscience innovation. Their expertise contributes to the continuous improvement and advancement of the company's product portfolio.
- Furthermore, PURE Biosciences Inc has successfully built strategic partnerships with key industry players. These partnerships enable the company to access valuable resources, such as distribution channels and market expertise, which enhance its market presence and customer reach. This collaborative approach enhances the company's competitive advantage.
Weaknesses
- Despite its strengths, PURE Biosciences Inc also faces certain weaknesses that need to be addressed. One weakness is the company's heavy reliance on a limited number of major customers. Any disruptions in these customer relationships or changes in their demands could significantly impact PURE Biosciences' revenue stream.
- Additionally, PURE Biosciences Inc operates in a highly competitive market. The presence of numerous competitors poses a challenge to the company's market share and pricing power. To maintain its competitive edge, PURE Biosciences needs to continuously invest in R&D and stay ahead of technological advancements.
Opportunities
- Various opportunities exist for PURE Biosciences Inc to capitalize on in the market. Firstly, the growing demand for eco-friendly and sustainable solutions presents an opportunity for the company to showcase its innovative bioscience technologies. By aligning its products with environmental consciousness, PURE Biosciences can attract environmentally conscious customers and gain market share.
- Additionally, the company can expand its product offerings into untapped markets. By identifying and targeting new industries or geographies, PURE Biosciences can diversify its revenue streams and reduce dependency on a limited customer base. Exploring strategic partnerships with distributors and suppliers in these new markets can accelerate growth and market penetration.
Threats
- PURE Biosciences Inc faces several threats that could potentially hinder its growth and profitability. One major threat is the stringent regulations governing the biosciences industry. Compliance with these regulations requires significant investment in resources and could result in delays in product development or market entry.
- Additionally, economic downturns or fluctuations in market demand can impact the willingness of customers to invest in innovative bioscience solutions. Changes in customer preferences or budget constraints could reduce the demand for PURE Biosciences' products, affecting its sales and revenue.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.